| Home Market Dynamics Sector Analysis Company Insights AI Investing Strategies Contact Us Login |
| AbbVie is making significant strides in the field of immunology, showcasing strong advancements and product development that contribute to its growth in this sector. The company is also focusing on innovative drug platforms, including peptide inhibitors and molecular glue degraders, which highlight its commitment to pushing the boundaries of drug therapies. However, challenges persist in the evolving product pipeline, with some delays and obstacles faced during the development of certain products like emraclidine. Overall, these factors illustrate a dynamic environment for AbbVie as it navigates product/service development. |
| The price action of ABBVIE INC (ABBV) is impacted by broad market risk appetite, sector price trend, company-specific performance and market structure. The market sentiment at 0.4 is modestly bullish. Trend sentiment measures the current trend of the stock price, and market sentiment reflects what market participants collectively think where the price will move next.There is no clear direction for ABBV since trend sentiment and market sentiment are at the opposite directions. The positive sentiment force for sector is at 0.6, and the negative at -0.2 on 2025-01-28. The forces of and Valuation Sentiment (-1) will drive down the price. The forces of Stock Price Trend (0), Sector Price Trend (0), Price Level Sentiment (0), Option Sentiment (0), Market Risk Appetite (0), and Sentiment towards Fundamentals (3.5) will drive up the price. The sentiment for Sector Price Trend is calculated based on the price trend of related sector ETF. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Appetite is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. The price level reaches 100 at Bollinger upper band, and zero at lower band. |
| ABBV | |||||||||||||
| Date | Attention | Price | Price Level | Change | SMA10 Trend | Trend Sentiment | Hourly Trend | Hourly StdDev | Market Sentiment | Action | P | Fund. | News Sentiment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-01-28 | 0%(0%) | 0 | 0% | 0.4 | 3.5 | -1 | |||||||
| 2025-01-16 | 0%(0%) | 0 | 0% | 0.5 | 3.7 | -1 | |||||||
| 2025-01-10 | 0%(0%) | 0 | 0% | 0.4 | 3.4 | -1 | |||||||
| 2024-12-11 | 0%(0%) | 0 | 0% | 0.5 | 4 | -1 | |||||||
| 2024-12-06 | 0%(0%) | 0 | 0% | 0.5 | 4 | -1 | |||||||
| 2024-11-26 | 0%(0%) | 0 | 0% | 0.4 | 3.6 | -1 | |||||||
| 2024-11-19 | 0%(0%) | 0 | 0% | 0.4 | 3.1 | -1 | |||||||
| 2024-11-05 | 0%(0%) | 0 | 0% | 0.2 | 2.1 | -1 | |||||||
| 2024-11-04 | 0%(0%) | 0 | 0% | 0.2 | 2 | -1 | |||||||
| 2024-10-31 | 0%(0%) | 0 | 0% | 0.2 | 2.4 | -1 | |||||||
| Wait action is recommended in three scenarios with either high uncertainty or high risk: 1. The trend sentiment and market sentiment are at the opposite directions. 2. Both trend sentiment and market sentiment are positive, but the price level is elevated. 3. Both trend sentiment and market sentiment are negative, but the price level is depressed. In an uptrend, as an investor, you may want to wait for the pullback to open long position. In a downtrend, the price will likely rebound after huge decline. As an investor, you may want to wait for the rebound to exit long position. | |||||||||||||
| Market sentiment will accelerate the current trend when both trend sentiment and market sentiment are at the same direction. Market sentiment will generate volatility when it's at the opposite direction of the trend sentiment. News sentiment measures the daily emotion of the market. News sentiment may impact the daily price change while market sentiment is a more stable and consistent moving force. | |||||||||||||
| 2025-06-11 22:47:39 The relationship between high dividend yields and indicators of intrinsic value in investment selection. |
| 2025-06-11 22:47:39 The benefit of dividend reinvestment leading to better investment returns over long time frames. |
| 2025-06-11 22:47:39 Investor interest in the performance and market dynamics surrounding immunology drugs in the pharmaceutical sector. |
| 2025-06-11 22:47:39 The appeal of high-yield dividend stocks and their long-term outperformance as a reliable investment strategy. |
| 2025-06-11 22:47:39 Discussion on the expected sales performance and earnings announcements of AbbVie, particularly focusing on its key products. |